Glenmark Pharmaceuticals Limited

NSE: GLENMARKHealthcareLot size: 375

Glenmark Pharmaceuticals Limited Open Interest & PCR Analysis

₹2437.20Updated 4 Sept 2026, 03:30 pm IST
PCR
0.61Bearish signal
Max Pain
₹2400Spot above by ₹37
Total CE OI
1.82MCall writers
Total PE OI
1.11MPut writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
AI AnalysisGenerated daily after market close · AI-powered

OI Buildup Pattern

The open‑interest (OI) for the current weekly expiry shows a neutral buildup, meaning that price action has been flat while OI remains unchanged. A neutral buildup implies that neither long nor short participants are adding to their positions in a decisive manner; the market is essentially holding its existing exposure. Consequently, the lack of directional pressure suggests that traders are awaiting a catalyst before committing additional capital.

Put‑Call Ratio

The put‑call ratio (PCR) stands at 0.611, marginally lower than yesterday’s 0.618. A PCR below one denotes a dominance of call contracts, indicating a mildly bullish bias among option writers for this expiry.

Futures OI

Futures open interest registers zero change, with the net OI remaining unchanged from the prior session. This stability in futures OI reinforces the notion that market participants are not altering their directional bets and are maintaining their current exposure levels.

Data Summary

Overall, the total OI for the current expiry is 18,17,250 contracts, with call OI at 11,11,125, reflecting a balanced but slightly call‑heavy positioning environment.

Data as of 2026-09-04

Frequently Asked Questions

What is Glenmark Pharmaceuticals Limited PCR (Put-Call Ratio) today?
Glenmark Pharmaceuticals Limited's current PCR is 0.61. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Glenmark Pharmaceuticals Limited's PCR of 0.61 indicates bearish sentiment.
What is Glenmark Pharmaceuticals Limited OI buildup type today?
Glenmark Pharmaceuticals Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Glenmark Pharmaceuticals Limited?
Glenmark Pharmaceuticals Limited has total CE (call) OI of 1817250 contracts and total PE (put) OI of 1111125 contracts for the nearest expiry. The PCR is 0.61.
How is open interest analysis useful for Glenmark Pharmaceuticals Limited trading?
OI analysis for Glenmark Pharmaceuticals Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Glenmark Pharmaceuticals Limited?
Glenmark Pharmaceuticals Limited's max pain is ₹2,400 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.